Replies to post #1886 on Galectin Therapeutics Inc. (GALT)

[biotech2010]

You are obviously clueless about GALT's history and Platt taking the company share price from $35 to $0.25 during his tenure as CEO.

I have no interest in this conversation, I will go back to quietly waiting for the Phase 2 trials to be completed. I have added over 5,000 GALT shares to my holdings over the past 6 months, GLTA.